Participate in a Study
  • Science37 and PatientsLikeMe logos, with the tagline “Powered by Fuze Health.
    NEWS

    PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients

    Partnership combines trusted patient communities with flexible trial participation options to help sponsors enroll faster and retain patients.
    Read the Press Release
  • Science 37 and Tufts Center for the Study of Drug Development partner logos against a transparent background.
    NEWS

    Science 37 and Tufts CSDD
    Publish Landmark Study

    on Direct-to-Patient Clinical Trial Site Performance Outperforming Industry Benchmarks
    Read the Peer-Reviewed Analysis

  • One Site. Any Patient.
    Total Access.

    Science 37 is the industry-leading patient access company dedicated to supporting clinical trial enrollment through patient-and site-centric solutions.
    Science 37 compliance icon featuring a green seal with the text "FDA Inspected" and three stars.

    The First & Only
    FDA-Inspected
    Direct-to-Patient Site

hello world!
  • Science37 and PatientsLikeMe logos, with the tagline “Powered by Fuze Health.
    NEWS

    PatientsLikeMe and Science 37
    Partner to Unlock Trial Access for Interested, Eligible Patients

    Partnership combines trusted patient communities with flexible trial participation options to help sponsors enroll faster and retain patients.
    Read the Press Release
  • Science 37 and Tufts Center for the Study of Drug Development partner logos against a transparent background.
    NEWS

    Science 37 and Tufts CSDD
    Publish Landmark Study

    on Direct-to-Patient Clinical Trial Site Performance Outperforming Industry Benchmarks
    Read the Peer-Reviewed Analysis

  • One Site. Any Patient.
    Total Access.

    Science 37 is the industry-leading patient access company dedicated to supporting clinical trial enrollment through patient-and site-centric solutions.
    Science 37 compliance icon featuring a green seal with the text "FDA Inspected" and three stars.

    The First & Only
    FDA-Inspected
    Direct-to-Patient Site

hello world!
Top News
hello world!

Science 37 is a modern clinical research site that delivers trials directly to patients' homes.

Science 37 compliance icon featuring a green seal with the text "FDA Inspected" and three stars.

The First & Only
FDA-Inspected Direct-to-Patient Site

The First & Only
FDA-Inspected
Direct-to-Patient Site

Five Phase 3 Trials Inspected:

  • No Action Indicated (NAI) classification
  • No objectionable conditions noted
  • No Form 483 issued
  • No recommendations
Our Clinical Trial Track Record

Science 37 was founded more than a decade ago by investigators with the vision to make clinical research accessible to anyone, anywhere, anytime, regardless of their proximity to research sites.

We carry that vision forward through the expertise of world-class clinical research professionals who develop customized solutions that help patients discover, qualify for, and participate in studies—regardless of their social determinants of health.

Redefining Clinical Trial Participation:
Proven, Inspected, and Trusted.

Tufts University Center for the Study of Drug Development logo

Tufts CSDD
Validated

Peer-reviewed data proves our site delivers on higher enrollment, better retention, and faster timelines.

FDA-Inspected Across
Five Phase 3 Studies

Successfully completed with zero Form 483s issued.

200+ Trials
Supported

Therapeutic area agnostic.

A Look at Our Enrollment Performance.

Our contribution to enrollment is often among the highest across study sites.
FDA Inspected & Approved

Primary Biliary Cholangitis
Phase 3, Pivotal

47%

of total U.S. study participants
FDA Inspected

Asthma
Phase 3, Pivotal

28%

of total study participants
FDA Inspected

Narcolepsy
Phase 4

55%

of total study participants

Fragile X Syndrome
Phase 3

25%

of total study participants

COVID-19 Prophylaxis
Phase 3

42%

of total study participants

Cholestatic Pruritus
Phase 2

21%

of total study participants
Explore Our Trial Success Stories

Patients are more than just a number.
They want to participate on their terms.

Patients are more than just a number. They want to participate on their terms.

For Trial Sponsors:
Expand access. Enhance diversity. Optimize enrollment.



The right patients are waiting—let them find and enroll in your trial with ease. Science 37’s Direct-to-Patient Site eliminates the barriers of awareness and geography, expanding your trial's reach to 100% of the U.S. patient population. From simple to complex studies, our experienced investigators, research-grade nurses, and coordinators ensure high-quality execution every time.
Optimize Your Trial Enrollment
Healthcare professional preparing a centrifuge and sample collection supplies beside a seated patient during a home visit.
For Patients:
Participation, on your terms.

Life moves quickly—participating in research should keep up. Join clinical trials from anywhere, with no barriers of location, scheduling, or inconvenience. Whether it's from your living room or while you're traveling, our study team is with you every step of the way, ensuring a seamless experience no matter where life takes you.
Participate in a Study
Healthcare professional using a tuning fork to examine a patient’s hand at home during a video consultation.

Some of Our Partners.

Just some of the incredible partners powering our mission to bring clinical research to patients.
Acer Therapeutics
Adrenas
Advarra
Anthos Therapeutics
Avillion
Bayer
Biohaven
Boehringer Ingelheim
Catalent
Chugai Pharmaceutical
Delfi
Escient Pharmaceuticals
GSK
Harmony Biosciences
Jazz Pharmaceuticals
LabConnect
Mirum Pharmaceuticals
PatientsLikeMe logo with the tagline “Powered by Fuze Health.
PatientsLikeMe
PureTech Health
RxE2
Debra Weinstein, MD, Chief Medical Officer at Science37
Debra Weinstein, MD
Ankush Bansal, MD, Internal Medicine Investigator at Science37
Ankush Bansal, MD
Sheila Woodhouse, MD, Medical Director of Cardiology at Science37
Sheila Woodhouse, MD
Christopher Reist, MD, Medical Director of Psychiatry at Science37
Christopher Reist, MD

The industry’s most experienced investigators in direct-to-patient, hybrid, and decentralized trials.

Meet Our Broadly-Licensed Physicians

We're actively recruiting and enrolling patients across a range of therapeutic trials.

Cardiovascular

Central Nervous System

Dermatology

Endocrinology

Gastroenterology

Hematology

Immunology

Infectious Disease

Men’s Health

Musculoskeletal

Oncology

Ophthalmology

Respiratory

Urology

Women’s Health

See Our Enrolling Studies

Trusted by Sponsors. Loved by Patients.

“At GSK, [we leverage] technology and remote services in order to make trials more accessible for participation. Science 37’s innovative services meant we could bring the trial to the [homes of patients] in rural areas who would typically have to travel hundreds of miles to the nearest clinical site…”
–Brandon Maggio, Global Head of Digital Operations & Process Optimization, GSK
“The people involved in the trial make all the difference. Especially in an oncology trial where a nurse comes into your home for two hours at a time; it means a lot if they’re personable and you don’t feel like you’re being treated like a statistic, you’re being treated like a human.”
–Study Participant

Connect with our team to explore how we can
enhance patient access and enrollment for your trial.

Connect with our team to explore how we can enhance patient access and enrollment for your trial.

© 
2026
 Science 37 | All Rights Reserved